AGIO
Price
$27.71
Change
-$0.73 (-2.57%)
Updated
Apr 3 closing price
Capitalization
1.59B
27 days until earnings call
AXON
Price
$539.69
Change
-$18.73 (-3.35%)
Updated
Apr 3 closing price
Capitalization
41.91B
39 days until earnings call
Ad is loading...

AGIO vs AXON

Header iconAGIO vs AXON Comparison
Open Charts AGIO vs AXONBanner chart's image
Agios Pharmaceuticals
Price$27.71
Change-$0.73 (-2.57%)
Volume$634.78K
Capitalization1.59B
Axon Enterprise
Price$539.69
Change-$18.73 (-3.35%)
Volume$662.05K
Capitalization41.91B
AGIO vs AXON Comparison Chart
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. AXON commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and AXON is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AGIO: $27.71 vs. AXON: $539.69)
Brand notoriety: AGIO and AXON are both not notable
AGIO represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: AGIO: 94% vs. AXON: 74%
Market capitalization -- AGIO: $1.59B vs. AXON: $41.91B
AGIO [@Biotechnology] is valued at $1.59B. AXON’s [@Aerospace & Defense] market capitalization is $41.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $200.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B. The average market capitalization across the [@Aerospace & Defense] industry is $16.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileAXON’s FA Score has 1 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • AXON’s FA Score: 1 green, 4 red.
According to our system of comparison, AXON is a better buy in the long-term than AGIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 4 TA indicator(s) are bullish while AXON’s TA Score has 3 bullish TA indicator(s).

  • AGIO’s TA Score: 4 bullish, 6 bearish.
  • AXON’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, AXON is a better buy in the short-term than AGIO.

Price Growth

AGIO (@Biotechnology) experienced а -10.15% price change this week, while AXON (@Aerospace & Defense) price change was -1.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -3.14%. For the same industry, the average monthly price growth was -1.34%, and the average quarterly price growth was +14.45%.

Reported Earning Dates

AGIO is expected to report earnings on May 01, 2025.

AXON is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (-3.14% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($41.9B) has a higher market cap than AGIO($1.59B). AXON has higher P/E ratio than AGIO: AXON (112.44) vs AGIO (2.44). AXON YTD gains are higher at: -9.192 vs. AGIO (-15.673). AXON has higher annual earnings (EBITDA): 437M vs. AGIO (-420.08M). AXON has more cash in the bank: 986M vs. AGIO (894M). AGIO has less debt than AXON: AGIO (57M) vs AXON (722M). AXON has higher revenues than AGIO: AXON (2.08B) vs AGIO (36.5M).
AGIOAXONAGIO / AXON
Capitalization1.59B41.9B4%
EBITDA-420.08M437M-96%
Gain YTD-15.673-9.192171%
P/E Ratio2.44112.442%
Revenue36.5M2.08B2%
Total Cash894M986M91%
Total Debt57M722M8%
FUNDAMENTALS RATINGS
AGIO vs AXON: Fundamental Ratings
AGIO
AXON
OUTLOOK RATING
1..100
6583
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
92
Overvalued
PROFIT vs RISK RATING
1..100
10012
SMR RATING
1..100
1847
PRICE GROWTH RATING
1..100
8040
P/E GROWTH RATING
1..100
8564
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for AXON (92). This means that AGIO’s stock grew somewhat faster than AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (12) in the Biotechnology industry is significantly better than the same rating for AGIO (100). This means that AXON’s stock grew significantly faster than AGIO’s over the last 12 months.

AGIO's SMR Rating (18) in the Biotechnology industry is in the same range as AXON (47). This means that AGIO’s stock grew similarly to AXON’s over the last 12 months.

AXON's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for AGIO (80). This means that AXON’s stock grew somewhat faster than AGIO’s over the last 12 months.

AXON's P/E Growth Rating (64) in the Biotechnology industry is in the same range as AGIO (85). This means that AXON’s stock grew similarly to AGIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOAXON
RSI
ODDS (%)
Bullish Trend 1 day ago
58%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
69%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 4 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
View a ticker or compare two or three
Ad is loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STKL4.48-0.23
-4.88%
SunOpta
UXIN4.04-0.26
-6.05%
Uxin Limited
APAM37.00-3.22
-8.01%
Artisan Partners Asset Management
MAS64.15-6.91
-9.72%
Masco Corp
LVO0.62-0.09
-12.94%
LiveOne

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with AXON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
-2.57%
AXON - AGIO
45%
Loosely correlated
-3.35%
OLMA - AGIO
44%
Loosely correlated
+0.60%
INSM - AGIO
44%
Loosely correlated
-0.15%
CORT - AGIO
41%
Loosely correlated
-5.30%
RAPT - AGIO
41%
Loosely correlated
-4.31%
More